CADL NASDAQ
Candel Therapeutics, Inc.
1W: -4.5%
1M: -26.3%
3M: -12.2%
YTD: +51.6%
1Y: +52.8%
3Y: +816.7%
5Y: -16.4%
$8.25
+0.46 (+5.91%)
Weekly Expected Move ±6.7%
$7
$7
$8
$9
$9
Credit Risk of going bust: higher than 54% of companies Debt: 7.3% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.09 (down 99%), Candel Therapeutics, Inc. would be worth roughly what it owes.
Total debt $49.5M against a stock market value of $631.3M.
Distance to default 4.70 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $23.9M (short-term plus half of long-term), stock volatility 69.0%; Altman Z'' 0.59. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.09 (down 99%), Candel Therapeutics, Inc. would be worth roughly what it owes.
Total debt $49.5M against a stock market value of $631.3M.
Distance to default 4.70 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $23.9M (short-term plus half of long-term), stock volatility 69.0%; Altman Z'' 0.59. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
2 relationships2
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2025-08-21
Earliest Filing
2026-02-19
Latest Filing
investor: 1
partner: 1
Counterparties (Filed by CADL)
2 relationshipsCompanies named in CADL's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| RTW Investments, LP | — | investor | Agreed to pay $100 million in royalty funding upon FDA approval of Candel's product CAN-2409 in exchange for tiered roya | 2026-02-19 | View |
| 117 Kendrick DE, LLC | — | partner | Landlord in lease amendment for office space at 117 Kendrick Street, Needham, MA. | 2025-08-21 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-10 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-09-09 | Regulation FD; Exhibits | View | |
| 2026-08-13 | Earnings Release; Exhibits | View | |
| 2026-06-24 | Shareholder Vote | View | |
| 2026-06-16 | Officer/Director Change; Exhibits | View | |
| 2026-05-15 | Regulation FD; Exhibits | View | |
| 2026-05-14 | Earnings Release; Exhibits | View | |
| 2026-03-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-02-23 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2026-02-19 | Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Regulation | Agreement | View |
| 2025-12-05 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-11-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-14 | Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Creation of | Agreement | View |
| 2025-08-21 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-08-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-24 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
| 2025-06-23 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-06-18 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-06-06 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-05-28 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR